These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 18547473

  • 1. Stability of sirolimus and everolimus measured by immunoassay techniques in whole blood samples from kidney transplant patients.
    Capone D, Gentile A, Polichetti G, Federico S, Sabbatini M, Acampora A, Basile V, Pieri M, Tarantino G.
    Int J Immunopathol Pharmacol; 2008; 21(2):297-307. PubMed ID: 18547473
    [Abstract] [Full Text] [Related]

  • 2. Quantification of sirolimus and everolimus by immunoassay techniques: test specificity and cross-reactivity evaluation.
    Pieri M, Miraglia N, Gentile A, Polichetti G, Castiglia L, Federico S, Sabbatini M, Basile V, Tarantino G, Acampora A, Capone D.
    Int J Immunopathol Pharmacol; 2008; 21(3):585-94. PubMed ID: 18831925
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Liquid chromatography-tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation.
    Moes DJ, Press RR, de Fijter JW, Guchelaar HJ, den Hartigh J.
    Ther Drug Monit; 2010 Aug; 32(4):413-9. PubMed ID: 20535052
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of a fluorescent polarization immunoassay for whole blood everolimus determination using samples from renal transplant recipients.
    Salm P, Warnholtz C, Boyd J, Arabshahi L, Marbach P, Taylor PJ.
    Clin Biochem; 2006 Jul; 39(7):732-8. PubMed ID: 16725133
    [Abstract] [Full Text] [Related]

  • 7. Determination of everolimus in whole blood using the Abbott IMx sirolimus microparticle enzyme immunoassay.
    Bouzas L, Tutor JC.
    Clin Biochem; 2007 Jan; 40(1-2):132-6. PubMed ID: 17011541
    [Abstract] [Full Text] [Related]

  • 8. Comparison of fluorescent polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantation.
    Khoschsorur G, Fruehwirth F, Zelzer S, Stettin M, Halwachs-Baumann G.
    Clin Chim Acta; 2007 May 01; 380(1-2):217-21. PubMed ID: 17320846
    [Abstract] [Full Text] [Related]

  • 9. Determination of everolimus in blood samples from kidney and liver transplant recipients using the sirolimus chemiluminescence magnetic microparticle immunoassay (CMIA) on the Architect-i1000® system.
    Hermida-Cadahia EF, Tutor JC.
    Scand J Clin Lab Invest; 2012 Apr 01; 72(2):180-3. PubMed ID: 22248047
    [Abstract] [Full Text] [Related]

  • 10. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.
    Koster RA, Alffenaar JW, Greijdanus B, Uges DR.
    Talanta; 2013 Oct 15; 115():47-54. PubMed ID: 24054560
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison between a liquid chromatography-tandem mass spectrometry assay and a fluorescent polarization immunoassay to measure whole blood everolimus concentration in heart and renal transplantations.
    Dailly E, Deslandes G, Hourmant M, Petit T, Renaud C, Treilhaud M, Jolliet P.
    J Clin Lab Anal; 2008 Oct 15; 22(4):282-5. PubMed ID: 18623123
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry.
    van der Heijden J, de Beer Y, Hoogtanders K, Christiaans M, de Jong GJ, Neef C, Stolk L.
    J Pharm Biomed Anal; 2009 Nov 01; 50(4):664-70. PubMed ID: 19155152
    [Abstract] [Full Text] [Related]

  • 14. Measurement of sirolimus in whole blood using high-performance liquid chromatography with ultraviolet detection.
    Holt DW, Lee T, Johnston A.
    Clin Ther; 2000 Nov 01; 22 Suppl B():B38-48. PubMed ID: 10823372
    [Abstract] [Full Text] [Related]

  • 15. Analytical performance of QMS everolimus assay on ortho Vitros 5,1 FS fusion analyzer: measuring everolimus trough levels for solid organ transplant recipients.
    Shu I, Wright AM, Chandler WL, Bernard DW, Wang P.
    Ther Drug Monit; 2014 Apr 01; 36(2):264-8. PubMed ID: 24232125
    [Abstract] [Full Text] [Related]

  • 16. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
    Koster RA, Dijkers EC, Uges DR.
    Ther Drug Monit; 2009 Feb 01; 31(1):116-25. PubMed ID: 19065123
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of QMS everolimus assay using Hitachi 917 Analyzer: comparison with liquid chromatography/mass spectrometry.
    Dasgupta A, Davis B, Chow L.
    Ther Drug Monit; 2011 Apr 01; 33(2):149-54. PubMed ID: 21266941
    [Abstract] [Full Text] [Related]

  • 19. An immunoassay for the measurement of sirolimus.
    Jones K, Saadat-Lajevard S, Lee T, Horwatt R, Hicks D, Johnston A, Holt DW.
    Clin Ther; 2000 Apr 01; 22 Suppl B():B49-61. PubMed ID: 10823373
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the Innofluor certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantation.
    Baldelli S, Crippa A, Gabrieli R, Fiocchi R, Perico N, Merlini S, Ottomano C, Cattaneo D.
    Clin Biochem; 2006 Dec 01; 39(12):1152-9. PubMed ID: 17054930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.